Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

FLGT Fulgent Genetics Inc

Price (delayed)

$21.29

Market cap

$648.14M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.33

Enterprise value

$581.34M

Fulgent Genetics' proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high ...

Highlights
FLGT's EPS has soared by 76% year-on-year and by 6% since the previous quarter
The net income has soared by 75% YoY and by 4.5% from the previous quarter
Fulgent Genetics's debt has increased by 16% from the previous quarter and by 15% YoY

Key stats

What are the main financial stats of FLGT
Market
Shares outstanding
30.44M
Market cap
$648.14M
Enterprise value
$581.34M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.58
Price to sales (P/S)
2.24
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.99
Earnings
Revenue
$292.45M
Gross profit
$113.46M
Operating income
-$71.92M
Net income
-$40.78M
EBIT
-$48.38M
EBITDA
-$21.59M
Free cash flow
-$31.56M
Per share
EPS
-$1.33
EPS diluted
-$1.33
Free cash flow per share
-$1.02
Book value per share
$36.56
Revenue per share
$9.49
TBVPS
$34.08
Balance sheet
Total assets
$1.21B
Total liabilities
$82.97M
Debt
$476,000
Equity
$1.13B
Working capital
$350.87M
Liquidity
Debt to equity
0
Current ratio
6.32
Quick ratio
5.94
Net debt/EBITDA
3.09
Margins
EBITDA margin
-7.4%
Gross margin
38.8%
Net margin
-13.9%
Operating margin
-24.6%
Efficiency
Return on assets
-3.3%
Return on equity
-3.6%
Return on invested capital
-5.2%
Return on capital employed
-4.2%
Return on sales
-16.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

FLGT stock price

How has the Fulgent Genetics stock price performed over time
Intraday
0.57%
1 week
3.6%
1 month
3.65%
1 year
2.5%
YTD
15.27%
QTD
25.98%

Financial performance

How have Fulgent Genetics's revenue and profit performed over time
Revenue
$292.45M
Gross profit
$113.46M
Operating income
-$71.92M
Net income
-$40.78M
Gross margin
38.8%
Net margin
-13.9%
Fulgent Genetics's net margin has soared by 76% YoY and by 8% from the previous quarter
The net income has soared by 75% YoY and by 4.5% from the previous quarter
Fulgent Genetics's operating income has soared by 63% YoY and by 2.7% from the previous quarter
Fulgent Genetics's operating margin has soared by 63% YoY and by 6% from the previous quarter

Price vs fundamentals

How does FLGT's price correlate with its fundamentals

Growth

What is Fulgent Genetics's growth rate over time

Valuation

What is Fulgent Genetics stock price valuation
P/E
N/A
P/B
0.58
P/S
2.24
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.99
FLGT's EPS has soared by 76% year-on-year and by 6% since the previous quarter
The price to book (P/B) is 64% lower than the 5-year quarterly average of 1.6 but 16% higher than the last 4 quarters average of 0.5
FLGT's P/S is 23% below its 5-year quarterly average of 2.9 but 12% above its last 4 quarters average of 2.0
Fulgent Genetics's revenue has increased by 3.2% QoQ

Efficiency

How efficient is Fulgent Genetics business performance
The company's return on assets has surged by 74% YoY and by 6% QoQ
The return on equity has surged by 74% year-on-year and by 5% since the previous quarter
FLGT's ROS has soared by 70% year-on-year and by 8% since the previous quarter
The company's return on invested capital has surged by 70% YoY and by 3.7% QoQ

Dividends

What is FLGT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FLGT.

Financial health

How did Fulgent Genetics financials performed over time
FLGT's quick ratio is up by 32% since the previous quarter and by 26% year-on-year
FLGT's current ratio is up by 30% since the previous quarter and by 24% year-on-year
Fulgent Genetics's debt is 100% less than its equity
Fulgent Genetics's debt has increased by 16% from the previous quarter and by 15% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.